| Descriptor English: | Platelet Activating Factor | ||||||
| Descriptor Spanish: |
Factor de Activación Plaquetaria
| ||||||
| Descriptor Portuguese: | Fator de Ativação de Plaquetas | ||||||
| Descriptor French: | Facteur d'activation plaquettaire | ||||||
| Entry term(s): |
1 Alkyl 2 acetyl sn glycerophosphocholine 1-Alkyl-2-acetyl-sn-glycerophosphocholine AGEPC Acetyl Glyceryl Ether Phosphorylcholine Aggregating Factor, Platelet Factor, Platelet Activating PAF Acether PAF-Acether Phosphorylcholine, Acetyl Glyceryl Ether Platelet Activating Substance Platelet Aggregating Factor Platelet Aggregation Enhancing Factor Platelet-Activating Substance Thrombocyte Aggregating Activity |
||||||
| Tree number(s): |
D02.033.100.291.211.500 D02.092.063.291.211.500 D02.092.877.883.333.710 D02.675.276.232.710 D10.570.755.375.760.400.985.910 D23.119.865 D23.469.050.600 |
||||||
| RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D010972 | ||||||
| Scope note: | A phospholipid derivative formed by PLATELETS; BASOPHILS; NEUTROPHILS; MONOCYTES; and MACROPHAGES. It is a potent platelet aggregating agent and inducer of systemic anaphylactic symptoms, including HYPOTENSION; THROMBOCYTOPENIA; NEUTROPENIA; and BRONCHOCONSTRICTION. |
||||||
| Allowable Qualifiers: |
AA analogs & derivatives AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors AN analysis BI biosynthesis CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis DE drug effects DF deficiency EC economics GE genetics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PH physiology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UL ultrastructure UR urine |
||||||
| Previous Indexing: |
Lysophosphatidylcholines (1966-1980) |
||||||
| Public MeSH Note: | 1983; PLATELET AGGREGATING FACTOR was indexed under PLATLET ACTIVATING FACTOR 2002-2005 & BLOOD COAGULATION FACTORS 1979-2001 |
||||||
| History Note: | 1983(1979) |
||||||
| DeCS ID: | 23518 | ||||||
| Unique ID: | D010972 | ||||||
| Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||||
| Date Established: | 1983/01/01 | ||||||
| Date of Entry: | 1982/05/11 | ||||||
| Revision Date: | 2005/06/30 |
-
-
CHEMICALS AND DRUGS
Organic Chemicals [D02]Organic Chemicals -
CHEMICALS AND DRUGS
Organic Chemicals [D02]Organic Chemicals -
CHEMICALS AND DRUGS
Organic Chemicals [D02]Organic Chemicals -
CHEMICALS AND DRUGS
Organic Chemicals [D02]Organic Chemicals -
CHEMICALS AND DRUGS
Lipids [D10]Lipids -
CHEMICALS AND DRUGS
Biological Factors [D23]Biological Factors -
CHEMICALS AND DRUGS
Biological Factors [D23]Biological Factors
|
|
Platelet Activating Factor
- Preferred
| Concept UI |
M0017009 |
| Scope note | A phospholipid derivative formed by PLATELETS; BASOPHILS; NEUTROPHILS; MONOCYTES; and MACROPHAGES. It is a potent platelet aggregating agent and inducer of systemic anaphylactic symptoms, including HYPOTENSION; THROMBOCYTOPENIA; NEUTROPENIA; and BRONCHOCONSTRICTION. |
| Preferred term | Platelet Activating Factor |
| Entry term(s) |
1 Alkyl 2 acetyl sn glycerophosphocholine 1-Alkyl-2-acetyl-sn-glycerophosphocholine AGEPC Acetyl Glyceryl Ether Phosphorylcholine Aggregating Factor, Platelet Factor, Platelet Activating PAF Acether PAF-Acether Phosphorylcholine, Acetyl Glyceryl Ether Platelet Activating Substance Platelet Aggregating Factor Platelet Aggregation Enhancing Factor Platelet-Activating Substance Thrombocyte Aggregating Activity |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey
